The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Not Applicable
Recruiting
- Conditions
- CancerOncologyPharmacyDrug Prescriptions
- Registration Number
- NCT06566560
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2500
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients of all ages<br><br> - A clinical diagnosis of cancer using an oral anticancer drug that requires storage<br> at room temperature according to the Summary of Product Characteristics (SmPC).<br><br>Exclusion Criteria:<br><br> - Patients that do not understand the Dutch or English language, in written or spoken.<br><br> - Patients receiving prescriptions that contain an amount of tablets that deviates<br> from the regular package size, resulting in the pharmacy dispensing an opened<br> package
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The environmental impact of redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.;Cost-savings obtained by redispensing unused oral anticancer drugs of verified quality compared to standard practice of disposal.
- Secondary Outcome Measures
Name Time Method The proportion of usability of returned medication for redispensing and the reasons for quality disapproval.;The proportion of returned unused oral anticancer drugs and reasons thereof.;Patients' reasons for not wanting to participate in a redispensing program for oral anticancer drugs.